AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$HNGE

Budge James sold $5.0M of HNGE

Budge James (Chief Financial Officer) sold 55,561 shares of Hinge Health, Inc. (HNGE) at an average of $89.45 ($88.22–$91.62, $4.97M total) across 5 trades on 2026-09-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Budge James
Published Sep 11, 2026, 11:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 11:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HNGE
Bearish
medium confidence
Mentioned
$HNGE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishLow
01

Why it matters

The disclosed sale adds transparency but is unlikely to move the stock significantly.

02

Market read

Routine insider sale with modest dollar amount; limited trading relevance.

03

What to watch

Holding after sale remains sizable (349k shares), indicating continued confidence.

Relevance 5/10Novelty 4/10Timing: post‑market 2026-09-10

Background

Form 4 filing discloses insider transactions; investors monitor CFO sales for signals.

Company-level read

Ticker impact

$HNGEBearishMedium confidence
Context

CFO Budge James sold ~5M USD of HNGE shares via a 10b5-1 plan on 2026-09-10.

Expected impact

Potential slight dip in intraday price; limited longer‑term effect.

Evidence & confidence

CFO selling $5M signals possible insider confidence concerns, but 10b5-1 plans are pre‑arranged and common.

Market effects

Sector

Minimal impact on digital health sector; similar insider sales are routine.

Regional

No regional effect; confined to HNGE shareholders.

Global

Low global relevance.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event; price may remain stable.

Key entities

  • Person
    Budge James

    Chief Financial Officer of Hinge Health, Inc.

  • Company
    Hinge Health, Inc.

    Digital health company listed on Nasdaq under HNGE.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HNGE insider trading history →

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

investing.com
$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

finance.yahoo.com